August 07, 2025

Flu Treatment Linked to Lower Neuropsychiatric Risk in Pediatric and Adolescent Patients

Subgroup analyses demonstrated a greater reduction in neurologic events than psychiatric events, though the reduction in psychiatric events was not statistically significant.

Conexiant

August 06, 2025

New COVID Booster Matches Efficacy, Raises Antibodies

A phase 3 randomized trial found that Moderna’s next-generation COVID-19 vaccine, mRNA-1283, was non-inferior to the earlier mRNA-1273 vaccine in preventing COVID-19 and produced stronger neutralizing antibody responses.

Conexiant

August 06, 2025

UV Light Linked With Lower Respiratory Infection Rates 

Researchers found that germicidal UV light modestly reduced total respiratory infections in long-term care facilities for older adults.

Conexiant

August 06, 2025

Bimekizumab Sustains Psoriasis Response for 3 Years

A 3-year analysis of a phase IIIb trial found that bimekizumab, a dual interleukin-17A and interleukin-17F inhibitor, maintained high rates of skin clearance and demonstrated a consistent safety profile in patients with moderate-to-severe plaque psoriasis, including those who switched from secukinumab, an interleukin-17A inhibitor.

Conexiant

July 24, 2025

Maternal RSV Vaccine Shows 72% Effectiveness

Following national rollout, UK data provide early post-licensure evidence supporting maternal RSV vaccination as a real-world strategy to lower infant hospital admissions.

Conexiant

July 31, 2025

AAP Releases 2025-2026 Flu Guidance

Experts encourage early influenza vaccination in children to reduce severe illness and hospitalization, especially among medically vulnerable and underserved populations.

Conexiant

July 25, 2025

Spontaneous Urticaria Carries Greater Burden, Costs

Researchers assess how disease type, comorbidities, and treatment knowledge shape clinical outcomes and healthcare use in patients with chronic urticaria.

Conexiant

July 24, 2025

HHS Ends Thimerosal Use in Flu Vaccines

The U.S. Department of Health and Human Services has adopted a CDC advisory panel recommendation to remove thimerosal from all influenza vaccines, transitioning entirely to mercury-free, single-dose formulations.

Conexiant

July 24, 2025

Penicillin Allergy Label? Or Antibiotic Overuse?

Structured testing in primary care boosted penicillin prescribing fivefold, lowered overall antibiotic use, and proved cost-effective.

Conexiant